Cargando…
Quality assurance evaluation of delivery of respiratory‐gated treatments
We describe a method for evaluating the quality of respiratory‐gated radiation delivery using a commercially available device. During irradiation, gating traces for one field for each treatment were extracted from the system for each of 14 patients. The data were then transferred to a spreadsheet. S...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723481/ https://www.ncbi.nlm.nih.gov/pubmed/15753939 http://dx.doi.org/10.1120/jacmp.v5i3.2002 |
_version_ | 1783285221711413248 |
---|---|
author | Cardenas, Alex Fontenot, Jonas Forster, Kenneth M. Stevens, Craig W. Starkschall, George |
author_facet | Cardenas, Alex Fontenot, Jonas Forster, Kenneth M. Stevens, Craig W. Starkschall, George |
author_sort | Cardenas, Alex |
collection | PubMed |
description | We describe a method for evaluating the quality of respiratory‐gated radiation delivery using a commercially available device. During irradiation, gating traces for one field for each treatment were extracted from the system for each of 14 patients. The data were then transferred to a spreadsheet. Software was developed to evaluate the following parameters: duty cycle, amplitude of fiducial motion, fraction of amplitude of motion during gated delivery, and respiratory cycle time. Criteria were established for acceptability of gating traces. In our sample, over 85% of the traces indicated acceptability. An example of results for one patient extracted from analyzed gating traces is as follows: mean duty cycle, 57%; average amplitude of motion, 0.89 cm; average fraction of motion during gated delivery, 0.45; mean respiratory cycle time, 4.5 s. This technique can be used to evaluate delivery of respiratory‐gated radiation therapy for quality assurance purposes and to assess various techniques for improving delivery of gated therapy. A hard copy of the gating traces can be used to document gated treatment delivery for potential billing of the gated delivery process. PACS numbers: 87.53‐j, 87.53.Tf |
format | Online Article Text |
id | pubmed-5723481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57234812018-04-02 Quality assurance evaluation of delivery of respiratory‐gated treatments Cardenas, Alex Fontenot, Jonas Forster, Kenneth M. Stevens, Craig W. Starkschall, George J Appl Clin Med Phys Radiation Oncology Physics We describe a method for evaluating the quality of respiratory‐gated radiation delivery using a commercially available device. During irradiation, gating traces for one field for each treatment were extracted from the system for each of 14 patients. The data were then transferred to a spreadsheet. Software was developed to evaluate the following parameters: duty cycle, amplitude of fiducial motion, fraction of amplitude of motion during gated delivery, and respiratory cycle time. Criteria were established for acceptability of gating traces. In our sample, over 85% of the traces indicated acceptability. An example of results for one patient extracted from analyzed gating traces is as follows: mean duty cycle, 57%; average amplitude of motion, 0.89 cm; average fraction of motion during gated delivery, 0.45; mean respiratory cycle time, 4.5 s. This technique can be used to evaluate delivery of respiratory‐gated radiation therapy for quality assurance purposes and to assess various techniques for improving delivery of gated therapy. A hard copy of the gating traces can be used to document gated treatment delivery for potential billing of the gated delivery process. PACS numbers: 87.53‐j, 87.53.Tf John Wiley and Sons Inc. 2004-10-21 /pmc/articles/PMC5723481/ /pubmed/15753939 http://dx.doi.org/10.1120/jacmp.v5i3.2002 Text en © 2004 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Cardenas, Alex Fontenot, Jonas Forster, Kenneth M. Stevens, Craig W. Starkschall, George Quality assurance evaluation of delivery of respiratory‐gated treatments |
title | Quality assurance evaluation of delivery of respiratory‐gated treatments |
title_full | Quality assurance evaluation of delivery of respiratory‐gated treatments |
title_fullStr | Quality assurance evaluation of delivery of respiratory‐gated treatments |
title_full_unstemmed | Quality assurance evaluation of delivery of respiratory‐gated treatments |
title_short | Quality assurance evaluation of delivery of respiratory‐gated treatments |
title_sort | quality assurance evaluation of delivery of respiratory‐gated treatments |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723481/ https://www.ncbi.nlm.nih.gov/pubmed/15753939 http://dx.doi.org/10.1120/jacmp.v5i3.2002 |
work_keys_str_mv | AT cardenasalex qualityassuranceevaluationofdeliveryofrespiratorygatedtreatments AT fontenotjonas qualityassuranceevaluationofdeliveryofrespiratorygatedtreatments AT forsterkennethm qualityassuranceevaluationofdeliveryofrespiratorygatedtreatments AT stevenscraigw qualityassuranceevaluationofdeliveryofrespiratorygatedtreatments AT starkschallgeorge qualityassuranceevaluationofdeliveryofrespiratorygatedtreatments |